FOS.TO Stock News Phoscan Chemical Corp. (FOS.TO) 0.30 07/31/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Phoscan Chemical Corp. (FOS.TO) 0.30 $FOS.TO

PhosCan Chemical Announces Results of Annual and Special Meeting
Marketwire - Thu Jul 31, 1:58PM CDT
PhosCan Chemical Corp. (TSX: FOS) ("PhosCan" or the "Company" announces the results of its annual and special meeting of shareholders (the "Meeting" held in Toronto, Ontario on July 31, 2014.

PhosCan Chemical Announces Results for Quarter Ended April 30, 2014
Marketwire - Wed Jun 11, 4:03PM CDT
PhosCan Chemical Corp. (TSX: FOS) today released its quarterly results for the period ended April 30, 2014.

The GIS Market in Europe to Reach US$3,323.62 Million by 2016 Says Latest Report
M2 - Wed Jan 22, 4:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/rzbjkt/gis_market_in) has announced the addition of the "GIS Market in Europe 2012-2016" report to their offering. One of the key factors contributing to this market growth is the increasing demand from the Government sector. The GIS market in Europe has also been witnessing the development of integrated GIS systems. However, the need for high initial investment could pose a challenge to the growth of this market. The key vendors dominating this market space include EADS Astrium GmbH, Esri Inc., Hexagon AB, MacDonald, Dettwiler and Associates Ltd., and Ordnance Survey. The other vendors mentioned in this report are Autodesk Inc., Bentley Systems Inc., Digital Globe Inc., GE Energy, Geo Eye Inc., and Ubisense Group plc. Commenting on the report, an analyst from the Enterprise Computing team said: GIS market vendors are providing customized GIS solutions to meet specific industry requirements/applications as several end-users prefer customized GIS solutions to retain their competitiveness in the market. Customized GIS solutions are cost effective and this acts as a driving factor for its increased adoption over regular GIS solutions. The emergence of customized GIS solution also eliminates the need for high initial investment, and thus has increases its adoption. Therefore, the increasing focus on providing application-specific GIS solutions acts as a major trend in the GIS market in Europe. According to the report, one of the major drivers in the market is the increasing demand of GIS technology from Government sectors. Many government and military organizations are increasing investments in GIS technology to effectively increase national infrastructure and security. Further, the report states that one of the major challenges faced in the market is the need for high initial investment. GIS technology requires high capital investment which affects the growth of this market in industries such as Retail, Telecom, Real Estate, and Transportation and Logistics as complexities involved in acquiring real-time data increases the overall cost of GIS solutions. The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are Bentley Systems Inc., Autodesk Inc., GE Energy, GeoEye Inc., Ubisense Group plc, and Digital Globe Inc. For more information visit http://www.researchandmarkets.com/research/rz..._market_in About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Ulinzi Focused
by Francis Wadegu and Phillip Mbaji - All Africa Global Media - Wed Jan 22, 4:35AM CST
Ulinzi Stars head to Mombasa this Sunday for a 7-day training camp, where the soldiers will play build-up matches against Mombasa Combined and fellow Kenya Premier League side, Bandari at the Mombasa Municipal Stadium.

PhosCan Chemical Announces Results for Quarter Ended October 31, 2013
Marketwire - Fri Dec 13, 3:35PM CST
(All dollar amounts are expressed in Canadian currency unless otherwise noted.)

PhosCan Chemical Announces Results for Quarter Ended July 31, 2013
Marketwire - Fri Sep 13, 10:22AM CDT
(All dollar amounts are expressed in Canadian currency unless otherwise noted.)

Stockboard Custom Reports on Conifex Timber Inc. and PhosCan Chemical Corp.
ACCESSWIRE - Fri Sep 13, 8:00AM CDT
Custom stock reports and email news alert service for Conifex Timber Inc. (TSX VENTURE:CFF) and PhosCan Chemical Corp. (TSX:FOS) are now available on Stockboard.com

PhosCan Chemical Announces Results of Annual Meeting
Marketwire - Fri Jul 26, 10:42AM CDT
PhosCan Chemical Corp. (TSX: FOS) ("PhosCan" or the "Company" announces the results of its annual meeting of shareholders (the "Meeting" held in Toronto, Ontario on July 24, 2013.

PhosCan Chemical Announces Results for Year Ended January 31, 2013
Marketwire Canada - Fri Apr 26, 1:10PM CDT
(All dollar amounts are expressed in Canadian currency unless otherwise noted.)

PhosCan Chemical Provides Update for Martison Phosphate Project
Marketwire - Fri Mar 08, 9:26AM CST
PhosCan Chemical Corp. (TSX: FOS) ("PhosCan" or the "Company" is pleased to provide an update of activities at the Martison Phosphate Project.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 655

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 406

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 83

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 18

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

VivoPower Innovates with XRP-Focused Treasury Strategy

Updated Category News Views 359

VivoPower's Transformational XRP Strategy VivoPower International PLC (NASDAQ: VVPR) has recently embarked on a groundbreaking journey by announcing a new strategy centered on the digital asset XRP. The company is positioning itself as the first publicly traded entity to implement an XRP-focused digital asset treasury. This innovative approach is not only exciting for...

Continue Reading
Recognizing Excellence in Product Stewardship for 2024

Updated Category News Views 114

Celebrating Product Stewardship Excellence The Product Stewardship Society has announced a significant honor for 2024—Lynn L. Bergeson has been named the recipient of the prestigious Allan K. Fleeger Distinguished Service Award. This esteemed award has been established to acknowledge the remarkable contributions of individual product stewards who have played crucial...

Continue Reading
Gold Hits New Heights Amid Tensions and Election Uncertainty

Updated Category News Views 163

Gold Prices Surge to Record Heights In recent trading, gold prices have reached unprecedented levels, reflecting a significant rise driven by various factors, including political uncertainties and ongoing international conflicts. As anticipation surrounding a highly competitive U.S. presidential election grows, along with persistent tensions in regions such as the Middle...

Continue Reading
Paul Jebely Joins Sterlington as Aviation Law Vice Chair

Updated Category News Views 257

Paul Jebely Joins Sterlington as New Partner Sterlington PLLC is excited to announce that Paul Jebely has joined the firm as their new Partner and Vice Chair of International, marking a crucial advancement in their aviation law practice. Jebely is not just any attorney; he is a globally recognized authority in private aviation law, especially known for his work with...

Continue Reading
William James Wartinbee III Executes Significant Sell Strategy

Updated Category News Views 62

William James Wartinbee III Implements Key Sell Strategy In a noteworthy insider sale, William James Wartinbee III, the Executive Vice President at Gartner (IT), has sold 210 shares of the company. This transaction was documented in a Form 4 filing with the U.S. Securities and Exchange Commission, and the sale was valued at about $103,275. Examining Gartner's Current...

Continue Reading